We describe the largest series of ICI-induced AHA and the first case treated with emicizumab, a humanized bispecific monoclonal antibody that binds and bridges activated FIX and FX, partially mimicking FVIII activity. The gene discussed is F9; the disease is autoimmune hemolytic anemia.